Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Missense mutation
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== LMNA === [[File:LMNA_protein_(1IFR)_mutation_R527L_PMID_22549407.png|thumb|375px|upright=1.3|Wild type (left) and mutated (right) form of lamin A (pdb id: 1IFR). Normally, Arginine 527 (blue) forms [[Salt bridge (protein)|salt bridge]] with glutamate 537 (magenta), but R527L substitution results in breaking this interaction (leucine has a nonpolar tail and therefore cannot form a static salt bridge).]] DNA: 5' - AAC AGC CTG <span style="background-color:#ccf">CGT</span> ACG GCT CTC - 3' 3' - TTG TCG GAC <span style="background-color:#ccf">GCA</span> TGC CGA GAG - 5' mRNA: 5' - AAC AGC CUG CGU ACG GCU CUC - 3' Protein: [[Asparagine|Asn]] [[Serine|Ser]] [[Leucine|Leu]] [[Arginine|Arg]] [[Threonine|Thr]] [[Alanine|Ala]] [[Leucine|Leu]] [[LMNA]] missense mutation (c.1580G>T) introduced at LMNA gene β position 1580 (nt) in the DNA sequence (CGT) causing the [[guanine]] to be replaced with the [[thymine]], yielding CTT in the DNA sequence. This results at the protein level in the replacement of the [[arginine]] by the [[leucine]] at the position 527.<ref>{{cite journal |vauthors=Al-Haggar M, Madej-Pilarczyk A, Kozlowski L, Bujnicki JM, Yahia S, Abdel-Hadi D, Shams A, Ahmad N, Hamed S, Puzianowska-Kuznicka M |date=November 2012 |title=A novel homozygous p.Arg527Leu LMNA mutation in two unrelated Egyptian families causes overlapping mandibuloacral dysplasia and progeria syndrome |journal=European Journal of Human Genetics |volume=20 |issue=11 |pages=1134β1140 |doi=10.1038/ejhg.2012.77 |pmc=3476705 |pmid=22549407}}</ref> This leads to destruction of [[Salt bridge (protein)|salt bridge]] and structure destabilization. At [[phenotype]] level this manifests with overlapping [[mandibuloacral dysplasia]] and [[progeria syndrome]]. The resulting transcript and protein product is: DNA: 5' - AAC AGC CTG <span style="background-color:#ccf">CTT</span> ACG GCT CTC - 3' 3' - TTG TCG GAC <span style="background-color:#ccf">GAA</span> TGC CGA GAG - 5' mRNA: 5' - AAC AGC CUG CUU ACG GCU CUC - 3' Protein: [[Asparagine|Asn]] [[Serine|Ser]] [[Leucine|Leu]] [[Leucine|Leu]] [[Threonine|Thr]] [[Alanine|Ala]] [[Leucine|Leu]]
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)